Vator Securities advises SeaTwirl on 64.5 MSEK Rights Issue

24 November 2022

SeaTwirl is a Swedish energy tech company in wind power with the vision to become global leader in floating offshore wind farms. SeaTwirl’s unique floating vertical-axis wind turbine is simple and robust with few moving parts. This suits the conditions at sea and minimizes the need for maintenance, which leads to less downtime and operating hours. These are key requirements for reducing the costs associated with the production of energy.

On the back of the successfully installed 30 kW prototype, S1, which has been operating efficiently since 2015, SeaTwirl is focusing on the development of SX, the next generation floating wind turbine with +10MW turbine power. In parallel with the development of SX, the company intends to continue improving efficiency and production of the S2x wind turbine in Norway.

Read More

Vator Securities advises Stardots on 15 MSEK Private Placement

15 November 2022

Stardots is a deep tech company that brings together engineers and mathematicians with neurologists and life-science developers. The company’s initial focus is on Parkinson Disease, where the company’s digital platform, ANLIVA™, through mathematical models, sensor data and AI, analyses typical symptoms through the patient’s smartphone.

This is transformed into quantifiable symptom markers used for monitoring disease progression and optimizing treatment. Caregivers receive analysis, statistics and treatment suggestions based on the patient’s markers, allowing for individualized telemedicine treatment. Stardots’ vision is that its digital health platform ANLIVA™ will become a new standard for objective, equal, globally accessible, and cost-effective Parkinson’s care.

Read More

Vator Securities advises WntResearch on 40 MSEK Rights Issue

9 November 2022

WntResearch is a biotech company in oncology that develops the drug candidate Foxy-5 to prevent the development of cancer metastases. Foxy-5 is currently in the ongoing Phase 2 clinical study NeoFox.

The study includes patients with colon cancer in stage II/III, who at diagnosis, according to established assessment criteria, are considered to have a high risk of recurrence after the primary tumor has been surgically removed. Foxy-5 is a peptide that mimics the function of the protein WNT5A which is found naturally in the body, a protein that prevents the spread of cancerous cells in the body.

Read More

Vator Securities advises Plexian on 33 MSEK Rights Issue

31 October 2022

Plexian has developed the Edge platform, which is an innovative loyalty program. Edge, which is primarily based on business opportunities created through Open Banking, uses card-linked services that collect transaction data and purchase patterns.

Data is collected in order to create a better understanding of the user of Edge, and thereby be able to provide more personalized offers based on user data. Given that Plexian enters into partnerships with large member organizations where an existing user interface is already established, Edge is in a position to quickly reach a large number of users at a very low customer acquisition cost.

Read More

Vator Securities advises Urb-it on 196 MSEK Rights Issue

19 October 2022

Urb-it AB operates in the logistics sector and provides parcel delivery services. Customers can be found in a number of sectors, with a main focus on the e-commerce market. The business is operated through several subsidiaries in France, Great Britain and Spain.

“In short, the rights issue will enable us to strengthen our infrastructure, scale our operations across current and new markets and support growth as we execute on our mission to change urban logistics, one delivery at a time” says Urb-it’s CEO Kevin Kviblad.

Read More

Vator Securities advises JonDeTech on 42 MSEK Rights Issue

17 October 2022

JonDeTech is developing a cutting-edge sensor element architecture based on nanotechnology. The architecture enables the company to address multiple applications, including security applications, consumer electronics and smart buildings. A plastic construction makes JonDeTech’s sensor elements scalable at a low cost, enabling future volume production.

“This emission has been made possible by the great interest many investors have shown in our technology platform and we look forward to, with strengthened financials, move into a new phase and execute on our go-to market strategy during 2023”, comments Dean Tosic, CEO of JonDeTech.

Read More

Vator Securities advises ChromoGenics on 40 MSEK Rights Issue

6 October 2022

ChromoGenics is a proptech company producing smart dynamic glass that improves indoor environments and well-being and lowers buildings’ energy consumption, operating expenses and impact on the climate. The company’s product ConverLight® Dynamic is based on a unique patented technology from the Ångström Laboratory in Uppsala, where electrochromic coatings are sputtered onto plastic film.

All of ChromoGenics’ products strive to follow the key words environment and health. This means a focus on environmentally friendly material, lower energy consumption, increased access to daylight and views and improved indoor comfort.

Read More

Vator Securities advises Plagazi on 53 MSEK Private Placement

3 October 2022

Plagazi provides a leading, environmentally sustainable and economically attractive solution. Targeting the challenges of global warming (energy-related CO2 emissions) and the mounting waste problem, via the patented Plagazi Process building upon an innovative patented Plasma Gasification technology for converting waste into green hydrogen.

The offering is in the forefront, as it has the capability to transform even the most hazardous, and non-recyclable waste to energy, and allow for a full circular economy.

Read More